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OBJECTIVES The purpose of this study was to compare postoperative outcome in two groups of patients
with chronic severe aortic regurgitation (AR): those operated on early and those operated on
late according to the guidelines.
BACKGROUND The impact of earlier surgery for chronic severe AR as defined in guidelines has not been
evaluated.
METHODS A total of 170 patients with chronic severe AR submitted to aortic valve replacement were
prospectively followed up. Patients were divided in two groups depending on the clinical
situation at the time of surgery. Group A were 60 patients who were operated on following
guidelines advice of earlier surgery, and group B were 110 patients who were operated on late
with regard to guideline recommendations.
RESULTS Follow-up was 10  6 years (1 to 22 years). During follow-up 44 patients died, 7 patients
(12%) from group A and 37 (37%) from group B (p  0.001). The cause of death was
non-cardiac in 11 patients, 2 (3%) in group A and 9 (8%) in group B. Cardiac deaths occurred
in 33 patients, 5 (9%) from group A and 28 (28%) from group B (p 0.002). Causes of death
differed between groups A and B: heart failure or sudden death were significantly more
frequent in group B (20 patients vs. 1 patient, p  0.001). Overall survival in groups A and
B was 90  4% vs. 75  8% at 5 years, 86  5% vs. 64  5% at 10 years, and 78  7% vs.
53  6% at 15 years, respectively (p  0.009).
CONCLUSIONS Early operation as defined in the guidelines improves long-term survival in patients with
chronic AR. (J Am Coll Cardiol 2006;47:1012–7) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.049Cardiology Foundation
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dn recent years the natural history of chronic aortic regur-
itation (AR) has been well described, and several studies
ave clearly shown the predictors of unfavorable outcomes
1–5). It has been shown that a decrease of the left ventricular
jection fraction (LVEF) at rest increases the probability of
ymptoms at a rate of 25% per year (5), an end-systolic
iameter (ESD) 50 mm at a rate of 19% per year (5), and
ore recently that changes in LVEF and ESD predict
linical deterioration or death at an annual rate of 10% to
0% (6). On the other hand, postoperative outcome de-
ends on preoperative symptoms, preoperative LVEF, and
V dilation (7–9). In the American College of Cardiology/
merican Heart Association (ACC/AHA) guidelines (10),
urgery is considered a Class I recommendation in all
ymptomatic patients and in asymptomatic patients when
VEF at rest is lower than 49%, and a Class II recommen-
ation in asymptomatic patients with ESD55 mm. In the
ecommendations of the management of asymptomatic
atients with valvular heart disease from the European
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pain. This work was partially supported by Red Tematica de Investigación
ooperativa del Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo,
pain.m
Manuscript received May 31, 2005; revised manuscript received August 5, 2005,
ccepted October 17, 2005.ociety of Cardiology (ESC) (11), surgery is recommended
n severe AR with resting LVEF 50% or with enlarged
entricles end-diastolic diameter (EDD)70 mm and ESD
50 mm.
The aim of these recommendations is to offer a favorable
ostoperative long-term course. Although guidelines have
een available for some years, the real impact of earlier
urgery as defined in guidelines has not been evaluated, and
here is some concern about the real benefit of surgery in the
symptomatic patient (12–14).
In the present study we analyze the impact of adherence
o guidelines recommendations regarding earlier surgery on
he long-term postoperative outcome in a large series of
atients who were operated on in a single institution for
solated chronic severe AR according to a predefined pro-
ocol established in 1982 (15), similar to the subsequent
CC/AHA and ESC guidelines, which were designed in
he late 1990s.
ETHODS
tudy population. A total of 170 patients with severe
solated chronic AR and without significant coronary heart
isease were consecutively submitted to aortic valve replace-
ent in our institution between 1982 and 2002 according to
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March 7, 2006:1012–7 Outcome of Operated Aortic Regurgitationpredefined protocol (15) that advised surgery for all symp-
omatic patients and asymptomatic patients when ejection
raction (EF)50% and/or ESD is between 50 and 55 mm.
o patient was denied surgery because of preoperative very
evere LV dysfunction. Data regarding preoperative New
ork Heart Association (NYHA) functional class, symp-
oms, and echocardiographic parameters were analyzed.
atients were divided in two groups depending on the
linical situation at the time of surgery. Group A (“early”
urgery) included asymptomatic patients with moderate
egrees of LV dysfunction (LVEFs between 45% and 50%
nd/or ESDs between 50 and 55 mm) and patients in
YHA functional class II. Group B (“too late” surgery)
ncluded patients either severely symptomatic (NYHA
unctional class III and IV) or with an LVEF 45% or an
SD 55 mm. All patients were operated on by the same
urgical team. After surgery all patients were prospectively
ollowed up by a single cardiologist (P. T.) that followed
oth groups of patients in an exactly similar manner, with
he same clinical visits and drug therapy orientation in case
hey had heart failure or any other problem. Regular visits
ere scheduled at three months and yearly thereafter, and
chocardiograms were performed after one year and every
ve years. This study was approved by an institutional
eview committee and all subjects gave informed consent.
tatistical analysis. Descriptive analysis was performed
ith mean values  SD and range for continuous variables
nd absolute and relative frequencies of patients in each
ategory for categorical variables. Differences between study
roups were evaluated with the use of unpaired Student t
est for continuous variables and chi-square test for categor-
cal variables. Paired t test was used when appropriate. The
Table 2. Preoperative Clinical Status and Left
n
Age/Gend
(yrs, Male/Fem
Group A, n  60
NYHA FC I 26 43  17 (14–78)
NYHA FC II 34 51  13 (22–71)
Group B, n  110
NYHA FC I 27 44  13 (18–68)
NYHA FC II 17 49  14 (24–77)
NYHA FC III–IV 66 57  12 (27–77)
Abbreviations and Acronyms
ACC/AHA  American College of Cardiology/
American Heart Association
AR  aortic regurgitation
EDD  end-diastolic diameter
EF  ejection fraction
ESC  European Society of Cardiology
ESD  end-systolic diameter
LV  left ventricular/ventricle
NYHA  New York Heart Association*p  0.030; †p  0.0001.
Abbreviations as in Table 1.robability of survival during follow-up was calculated by
aplan-Meier analysis; the survival curves obtained were
ompared with the log-rank test (Mantel-Cox). Two Cox
odels were developed to assess the relative risk of cardio-
ascular death and death due to heart failure or sudden
eath. An additional analysis was also performed with the
ame methodology considering the two study groups only
n the basis of NYHA functional class (I to II vs. III to IV),
rrespective of the LVEF or LV dimensions of the patients.
A two-tailed value of p 0.05 was considered significant.
tatistical analysis was performed with the statistical pack-
ge SPSS 11.0 (SPSS Inc., Chicago, Illinois).
ESULTS
aseline characteristics. The study population is 170 pa-
ients, 135 men and 35 women, ages from 14 to 78 years,
ith a mean age of 50  14 years (median: 53 years). All
atients over 45 years had a normal coronary angiography.
roup A includes 60 patients: 26 (43%) were asymptomatic
atients with moderate LV dysfunction, and 34 patients
57%) were in NYHA functional class II. Group B includes
10 patients: 44 had either an LVEF 45% or an ESD
55 mm with either no symptoms or moderate symptoms,
nd 66 patients had severe symptoms (NYHA functional
lass III or IV). Demographic characteristics of the whole
eries are shown in Tables 1 and 2. All patients received
n aortic prosthesis, 101 (59%) mechanical and 69 (41%)
iological.
able 1. Preoperative Characteristics of Study Groups
Group A
n  60
Group B
n  110 p
ge (yrs) 47  15 53  14 0.025
ender (M/F) 49/11 86/24 NS
YHA FC
I 26 (43%) 27 (25%)
II 34 (57%) 17 (15%)
III 35 (32%)
IV 31 (29%)
DD (mm) 71  7 75  8 0.002
SD (mm) 48  6 55  10 0.0001
F (%) 54  7 42  10 0.0001
DD  end-diastolic diameter; EF  ejection fraction; ESD  end-systolic
iameter; FC  functional class; LV  left ventricle; NYHA  New York Heart
ssociation.
ricular Parameters of Study Groups
EDD (mm) ESD (mm) EF (%)
72  7 49  6 54  7
69  7 47  6 54  7
74  7 55  7 43  7
76  8 58  7 41  8
8 75  9 55  12 42  11Vent
er
ale)
24/2
* 25/9
23/4
15/2
† 46/1
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Outcome of Operated Aortic Regurgitation March 7, 2006:1012–7ostoperative clinical outcome. Hospital mortality was 12
atients (7%), 3 patients from group A (5%), and 9 (8%)
rom group B (p  0.5). Patients from group A who died
ere two patients with renal insufficiency (one with previous
enal transplant and one in hemodialysis program) and one
atient who had infection of the sternal wound and second-
ry sepsis.
Follow-up was 10  6 years (1 to 22 years) and only one
atient was lost to follow-up, and another was lost after 10
ears. During follow-up 44 patients died, 7 patients (12 %)
rom group A and 37 (37%) from group B, p  0.001
Table 3). The cause of death was non-cardiovascular in 11
atients (2 in group A and 9 in group B). Cardiovascular
eaths occurred in 33 patients, 5 from group A (9%) and 28
able 3. Causes of Late Mortality
Cardiovascular Death
n  33
Non-Cardiovascular Death
n  11
roup A,
n  7*
n  5† n  2
2 Coronary heart disease 1 Cancer
1 Sudden death 1 Respiratory infection
1 Stroke
1 Aortic disection
roup B,
n  37*
n  28† n  9
12 Heart failure 6 Cancer
8 Sudden death 1 Respiratory infection
3 Stroke 1 Alzheimer’s disease
2 Aortic disection 1 Suicide
1 Coronary heart disease
1 Abdominal aneurism
1 Infectious endocarditis
p  0.001; †p  0.002.
able 4. Clinical and Echocardiographic Status of 21 Patients W
Age, yrs;
Gender
NYHA FC EDD (mm)
Pre Post (1 yr) Pre Post (1 yr)
2; male 4 1 63 47
2; male 4 3 96 98
2; male 4 1 66 51
9; male 3 1 80 49
6; male 3 3 85 89
0; male 3 3 78 78
5, male 1 1 69 50
4; male 3 3 75 80
5; male 4 3 86 91
1; male 2 2 78 78
0; male* 4 3 90 85
9; male 4 3 85 88
2; male 4 2 73 65
6; male* 4 3 76 72
1; male 2 4 75 65
1; male 4 2 80 80
7; male 3 3 83 87
3; male 1 1 70 55
3; male* 4 3 77 82
0; female 4 2 71 62
7; male 1 1 79 54Death occurred while awaiting cardiac transplant.
HF  heart failure; SD  sudden death; other abbreviations as in Table 1.28%) from group B (p  0.002). Causes of death differed
etween groups A and B: heart failure and sudden death
ere significantly more frequent in group B (20 patients vs.
patient, p  0.001). Preoperative and one-year postoper-
tive clinical and echocardiographic data from patients
ying of heart failure and sudden death during follow-up are
hown in Table 4.
The relative risk of cardiac death through follow-up was
.91 in group B patients (95% confidence interval [CI] 1.1
o 7.5, p  0.028). Furthermore, the relative risk of death
ue to heart failure or sudden death was 10.35 in group B
atients (95% CI 1.39 to 77.26, p  0.023).
Overall survival in groups A and B was in the best-case
cenario (i.e., considering as alive the two patients with
ncomplete follow-up) 90  4% and 75  8% at 5 years,
6  5% and 64  5% at 10 years, and 78  7% and 53
6% at 15 years, respectively (p  0.009) (Fig. 1). In
he worst-case scenario, considering as death the two
atients with incomplete follow-up, the difference in
urvival of the two patient groups was still significant (p
0.028).
ostoperative echocardiographic outcome. At one year,
roup A postoperative echocardiograms showed an out-
tanding reduction in EDD (from 71  7 mm to 53  6
m, p  0.0001) and ESD (from 48  6 mm to 38  6
m, p  0.0001) and an increased LVEF (from 53  7%
o 57  9%, p  0.023). Group B patients also showed an
mprovement in EDD (from 75  8 mm to 59  12 mm,
 0.0001), ESD (from 55  10 mm to 44  14 mm,
 0.0001), and LVEF (from 42  10% to 47  16%, p 
.0001). This reduction occurred in both groups in the first
ied of Heart Failure or Sudden Death During Follow-Up
ESD (mm) EF (%) Cause and Timing
of Death; yr
PostopPost (1 yr) Pre Post (1 yr)
32 45 48 HF; 1
80 16 11 SD; 1
32 50 55 HF; 12
31 60 61 SD; 12
70 30 12 HF; 4
62 35 18 SD; 1
30 38 75 SD; 10
68 33 15 HF; 1
75 41 19 HF; 1
63 44 27 SD; 17
70 18 22 SD; 7
76 32 27 SD; 4
55 20 29 HF; 10
53 35 33 HF; 7
52 32 38 HF; 17
65 42 34 HF; 5
75 14 15 HF; 6
40 44 61 SD; 7
79 32 11 HF; 3
49 33 49 SD; 6
35 59 59 SD; 1ho D
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March 7, 2006:1012–7 Outcome of Operated Aortic Regurgitationear postoperative study and remained stable thereafter.
chocardiographic data are shown in Table 5.
At the end of follow-up survivors from group A were in
YHA functional class I (46 patients, 92%) or II (4
atients, 8%), and patients from group B were in NYHA
lass I (52 patients, 72%), II (11 patients, 21%), or III (1
atient, 7%). Final EDD, ESD, and LVEF in survivors
ere significantly worse in group B (p  0.021, 0.023, and
.047, respectively).
nalysis on the basis of preoperative NYHA functional
lass. Data were additionally analyzed on the basis of
ategorizing the population in preoperative NYHA func-
ional classes I to II (group A: n  104) versus III to IV
group B: n  66) irrespective of the LVEF or dimensions.
he main study results then disclosed a more marked
urvival difference between groups than with our original
lassification: operative mortality was now significantly greater
n group B (3% vs. 14%, p  0.01). During follow-up, 15
atients in group A (15%) and 29 (51%) in group B died (p
0.0001); deaths were cardiovascular in 10 (10%) from
roup A and in 23 (35%) from group B (p  0.0001). With
his new categorization, the relative risk of cardiac death in
roup B patients was 6.16. The 15-year survival was 76 
% in group A and 38  6% in group B (p  0.0001);
owever, echocardiographic improvement was less marked
n both groups: EDD at one year was 55  7 mm in group
and 61  15 mm in group B, ESD was 39  9 mm in
roup A and 46  16 mm in group B, and LVEF was 54 
1% in group A and 44  18% in group B.
ISCUSSION
he current ACC/AHA/ESC guidelines on the manage-
ent of AR are not based on randomized clinical trials but
Figure 1. Overall survival in study groups. pts.  patients.n observational studies that suggest that patients fulfilling Ahese criteria (5) are very likely to develop symptoms in the
ear future and on studies that have shown that the
ostoperative course is significantly worse in patients who
re operated on, either severely symptomatic or with severe
egrees of LV dysfunction (5,7–9). In the present study we
ave analyzed the long-term postoperative outcome of a
arge series of consecutive patients with isolated AR who
ave been operated on with pre-defined surgical indications.
ur surgical protocol included the operation of asymptom-
tic patients with either EF 50% or enlarged end-systolic
imensions (15). These indications are very similar to the
ubsequent ACC/AHA and ESC recommendations (10,11).
he present study is not a formal validation of the guide-
ines because, strictly speaking, a validation should entail a
ifferent design and the application to the patients of exactly
he same criteria as recommended; however, because our
olicy for the management of chronic AR was very close to
he subsequently developed guidelines, we think that our
ssessment of its effectiveness adds strengths to the recom-
endations of the latter, particularly regarding the benefits
f operation in selected asymptomatic patients.
We have considered that patients operated on “early”
ere those who were only moderately symptomatic or had a
oderate degree of LV dysfunction at the time of surgery.
ll group A patients fulfilled these criteria. In contrast,
atients considered to have been operated on “too late” were
hose with severe symptoms or with severely depressed LV
unction at the time of surgery. It might be wondered if
roup A patients include individuals who were operated on
oo early (i.e., before fulfilling the guidelines criteria for
peration). This is not the case, because no patient was
perated on that was asymptomatic and with LVEF 50%
nd ESD 55 mm. In fact, group A patients belong to a
ohort of AR patients with an extended preoperative
ollow-up in our department, in whom meticulous symp-
oms assessment was performed in each visit. In contrast,
ost group B patients were sent to us already with clear
easons for surgery, either severe symptoms or severely
epressed LVEF.
able 5. Comparison of Echocardiographic Parameters During
ollow-Up in Study Groups
Group A
n  60
Group B
n  110 p
DD (mm)
Preoperative 71  7 75  8 0.001
1-yr postoperative 53  6 59  12 0.0001
Final follow-up 53  7 57  9 0.021
SD (mm)
Preoperative 48  6 55  10 0.0001
1-yr postoperative 38  6 44  14 0.0001
Final follow-up 36  7 40  11 0.023
F (%)
Preoperative 54  7 42  10 0.0001
1-yr postoperative 57  9 47  16 0.0001
Final follow-up 55  9 51  12 0.047bbreviations as in Table 1.
t
r
g
w
n
o
o
e
s
d
m
f
i
A
p
i
p
s
o
O
A
d
n
a
w
t
h
s
r
u
l
t
a
o
f
(
h
t
p
p
r
i
o
w
p
e
n
a
u
i
d
m
o
n
f
o
g
r
r
t
e
w
m
s
r
t
a
a
t
t
s
t
e
t
A
T
f
R
C
1
R
1016 Tornos et al. JACC Vol. 47, No. 5, 2006
Outcome of Operated Aortic Regurgitation March 7, 2006:1012–7The results of the present series clearly reflect the long-
erm benefit of having surgery according to guidelines
ecommendations and validate the beneficial influence of
uidelines adherence toward early surgery. Overall survival
as statistically different between both groups. In group A,
o patient died of heart failure during follow-up, and only
ne patient died suddenly. The remaining four patients died
f causes that were unlikely to have been prevented by
arlier surgery. Also, at the end of follow-up, LV dimen-
ions and LVEF were normal in group A and statistically
ifferent from that of group B. Remarkably, in group B
ost cardiac deaths were either sudden or due to heart
ailure, and these death occurred in patients in whom no
mprovement of ventricular function occurred after surgery.
lthough a proportion of patients with poor preoperative
rognostic markers had an acceptable outcome, failure of
mprovement shortly after surgery identified a subset of
atients with particular poor prognosis, as previously de-
cribed (9).
Our results could be considered obvious, because patients
perated on in better conditions do better in the long term.
ne could then argue perhaps that all patients with severe
R should be operated on. There are several reasons to
elay surgery until guideline recommendations are reached:
atural history studies have clearly shown that asymptom-
tic patients with severe AR may remain asymptomatic and
ith preserved LV function for many years before reaching
he proposed operative values (5,13,16–20), and our data
ave demonstrated that when patients are operated on as
oon as these values occur, the postoperative outcome in
elation to LV function is excellent.
Therefore, it seems wise to defer surgery at least until
nfavorable predictors such as the ones reported in guide-
ines are present. That surgical indication should not await
he development of symptoms is well-illustrated by the
dditional analysis of our population classifying the patients
nly on the basis of NYHA functional class regardless of LV
unction. When classified in this way, group B patients
NYHA functional classes III to IV) had a predictably
igher operative mortality and poorer long-term survival
han with our original classification, whereas group A
atients, which now includes many with a markedly de-
ressed ventricular function, had a less marked long-term
ecovery of hemodynamic parameters. Although this behav-
or might seem too obvious, it nevertheless emphasizes that
ur categorization of patients in “early” and “late” surgery
as on the basis of sensible criteria.
Nevertheless, results in our group A patients reflect that
atients operated on early cannot avoid some mortality,
ither perioperative or during follow-up, probably related
ot to LV dysfunction but to aortic disease, endocarditis,
nd complications of the anticoagulation, all of which are
nlikely to benefit by earlier surgery. It might be wondered
f newer prostheses or surgical advances could, in the future,
ecrease these late mortality figures. In fact, our hospital
ortality rate can be considered high; however, 38% wereperated on in the 1980s and, as previously mentioned, in
o patient was surgery denied because of severe LV dys-
unction. Although our study clearly indicates the benefits
f early surgery, it has to be emphasized that the outcome in
roup B patients also indicates a benefit of surgery, both
egarding quality of life and ventricular function, and
einforces previous opinions that surgery should be offered
o all patients with severe aortic insufficiency, even with
xtreme degrees of dilation or LV dysfunction (21,22).
Certainly this is not a clinical trial, but a cohort study
here effectiveness of having followed established recom-
endations for early surgery in real life is assessed. This
tudy modality might not adjust for confounding as accu-
ately as a clinical trial. In this particular instance, however,
he number of confounding variables might not be so large
s to forbid adequate adjustment in an observational study
nd, indeed, our study design has the advantage of including
he whole population of patients with a very long follow-up,
hus providing a comprehensive view of the problem. In
ummary, our results illustrate how, in real clinical practice
he adherence to guidelines for early surgery have beneficial
ffect on the outcome of AR patients, stressing the impor-
ance of the routine implementation of guidelines.
cknowledgment
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